BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 2, 2026
Home » Authors » John Brosky

John Brosky

Articles

ARTICLES

Breakthroughs in imaging are seen changing the way cardiology is practiced

Oct. 1, 2008
By John Brosky
MUNICH, Germany — The noise and confusion from the bells and whistles being added to cardiology imaging are driving growth and greater revenues for manufacturers, but far more importantly, the steady stream of upgrades and new features is bringing breakthroughs in medical practice. Scientific sessions featuring abstracts and research papers using high-tech modalities for imaging the human heart have grown to more than 20% of the total 363 scientific sessions over the four days of the European Society of Cardiology's (ESC; Sophia Antipolis, France) annual congress here early last month. (Biomedical Business & Technology)
Read More

International report: bioMérieux takes second step toward cancer 'theranostics'

Sep. 25, 2008
By John Brosky

Good news fails to slow Agfa stock price's continued slide

Sep. 25, 2008
By John Brosky

Report from Europe: bioMérieux takes second step toward cancer 'theranostics'

Sep. 23, 2008
By John Brosky

Report from Europe: Good news fails to slow continued slide by Agfa

Sep. 22, 2008
By John Brosky

Philips' strategy for cardiac imaging leads with research

Sep. 18, 2008
By John Brosky
MUNICH, Germany — Philips Healthcare (Eindhoven, the Netherlands/Andover, Massachusetts) stood out among the dozens of manufacturers of cardiac imaging equipment for European markets jockeying for mind-share with the 24,000 cardiologists participating in the annual congress of the European Society of Cardiology (ESC; Sophia Antipolis, France) here earlier this month. (Diagnostics & Imaging Week)
Read More

New workstation creates novel views for cardiac imaging

Sep. 12, 2008
By John Brosky

Philips' strategy for cardiac imaging leads with research

Sep. 11, 2008
By John Brosky
MUNICH, Germany — Philips Healthcare (Eindhoven, the Netherlands/Andover, Massachusetts) stood out among the dozens of manufacturers of cardiac imaging equipment for European markets jockeying for mind-share with the 24,000 cardiologists participating in the annual congress of the European Society of Cardiology (ESC; Sophia Antipolis, France) here last week. (Medical Device Daily)
Read More

Scan of heart's magnetic field is revolutionizing diagnosis

Sep. 11, 2008
By John Brosky

Imaging breakthroughs are 'disrupting' cardiac practice

Sep. 11, 2008
By John Brosky
MUNICH, Germany — The noise and confusion from the bells and whistles being added to cardiology imaging are driving growth and greater revenues for manufacturers, but far more importantly, the steady stream of upgrades and new features is bringing breakthroughs in medical practice. (Diagnostics & Imaging Week)
Read More
View All Articles by John Brosky

Popular Stories

  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing